Glaucoma News

NEW ORLEANS — In this Healio video perspective, Michael Chaglasian, OD, FAAO, discusses the diagnostic efficacy of a modified Ocular Hypertension Treatment Study risk calculator, which he presented in a poster at the ARVO meeting.

SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, Reay H. Brown, MD, discusses the Omni Ergo-Series and Sion surgical instrument from Sight Sciences.

Higher levels of diglycerides and triglycerides were found to be associated with increased risk for primary open-angle glaucoma in a study.

Cigna Healthcare has updated its glaucoma surgical procedure policy to cover both ab interno canaloplasty and goniotomy to treat primary open-angle glaucoma, according to a press release from Sight Sciences.

As our population size increases and grows older, treatment of ocular disease will become more prominent in optometric practices. Consequently, the percentage of revenue generated by medical management will grow.

NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, Donald C. Hood, PhD, discusses how progression models may help detect the damage that glaucoma may cause to the circle of ganglion cells around the fovea.

Monitoring rates of ganglion cell/inner plexiform layer and circumpapillary retinal nerve fiber layer thinning may help determine glaucoma progression in eyes with suspected glaucoma, according to data published in JAMA Ophthalmology.

An eye drop bottle cap monitor measured and improved adherence in patients with glaucoma, with 80% of users experiencing at least a 90% adherence rate, according to data published in Journal of Glaucoma.

SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, I. Paul Singh, MD, discusses phase 3 data on the iDose TR implant from Glaukos.

VVN539 ophthalmic solution met its primary endpoints for the treatment of primary open-angle glaucoma or ocular hypertension in a phase 2 study, according to a press release from VivaVision Biotech.